Connection
Steven Rosenberg to Proto-Oncogene Proteins B-raf
This is a "connection" page, showing publications Steven Rosenberg has written about Proto-Oncogene Proteins B-raf.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.057 |
|
|
|
-
Goff SL, Rosenberg SA. BRAF Inhibition: Bridge or Boost to T-cell Therapy? Clin Cancer Res. 2019 05 01; 25(9):2682-2684.
Score: 0.540
-
Deniger DC, Kwong ML, Pasetto A, Dudley ME, Wunderlich JR, Langhan MM, Lee CR, Rosenberg SA. A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma. Clin Cancer Res. 2017 Jan 15; 23(2):351-362.
Score: 0.458
-
Arafeh R, Flores K, Keren-Paz A, Maik-Rachline G, Gutkind N, Rosenberg S, Seger R, Samuels Y. Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cells. Sci Rep. 2017 11 27; 7(1):16345.
Score: 0.031
-
Xi L, Pham TH, Payabyab EC, Sherry RM, Rosenberg SA, Raffeld M. Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma. Clin Cancer Res. 2016 Nov 15; 22(22):5480-5486.
Score: 0.028